nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00754	0.0587	CbGpPWpGaD
Treprostinil—PPARD—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.00554	0.0431	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.00549	0.0428	CbGpPWpGaD
Treprostinil—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00467	0.0364	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00443	0.0345	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors—VDR—psoriasis	0.00406	0.0316	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00383	0.0298	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—HCAR2—psoriasis	0.00354	0.0276	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—VDR—psoriasis	0.0032	0.0249	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SERPINB8—psoriasis	0.00317	0.0246	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00309	0.0241	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SERPINB8—psoriasis	0.00291	0.0227	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors—PPARG—psoriasis	0.00283	0.022	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00282	0.0219	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00259	0.0202	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—TGFA—psoriasis	0.00231	0.018	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.00223	0.0174	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—HCAR2—psoriasis	0.00215	0.0167	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—ICAM1—psoriasis	0.00204	0.0158	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.00203	0.0158	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—HCAR2—psoriasis	0.00197	0.0154	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.00196	0.0152	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00194	0.0151	CbGpPWpGaD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00191	0.0149	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCL20—psoriasis	0.00184	0.0143	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—JUN—psoriasis	0.00172	0.0134	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—SOCS1—psoriasis	0.00164	0.0128	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00157	0.0122	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—NOS2—psoriasis	0.00155	0.0121	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00146	0.0114	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—TARS—psoriasis	0.00142	0.011	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00135	0.0105	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—LEP—psoriasis	0.00121	0.00944	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—HCAR2—psoriasis	0.00121	0.00943	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—HCAR2—psoriasis	0.00112	0.00868	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL20—psoriasis	0.00111	0.00867	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HCAR2—psoriasis	0.0011	0.00857	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—PPARG—psoriasis	0.00106	0.00823	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL20—psoriasis	0.00103	0.00798	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HCAR2—psoriasis	0.00101	0.00788	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—CARM1—psoriasis	0.000927	0.00721	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ITGAL—psoriasis	0.000919	0.00716	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—JUN—psoriasis	0.00091	0.00708	CbGpPWpGaD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000891	0.00694	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ITGAL—psoriasis	0.000846	0.00659	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NDUFA5—psoriasis	0.000836	0.0065	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000836	0.0065	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000824	0.00641	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000815	0.00634	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000779	0.00607	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP2S1—psoriasis	0.000711	0.00553	CbGpPWpGaD
Treprostinil—Infection—Hydrocortisone—psoriasis	0.000704	0.000808	CcSEcCtD
Treprostinil—Insomnia—Mycophenolate mofetil—psoriasis	0.000704	0.000807	CcSEcCtD
Treprostinil—Dyspepsia—Cyclosporine—psoriasis	0.000702	0.000805	CcSEcCtD
Treprostinil—Nausea—Hydroxyurea—psoriasis	0.000699	0.000802	CcSEcCtD
Treprostinil—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000699	0.000802	CcSEcCtD
Treprostinil—Pruritus—Mycophenolic acid—psoriasis	0.000697	0.0008	CcSEcCtD
Treprostinil—Shock—Hydrocortisone—psoriasis	0.000697	0.0008	CcSEcCtD
Treprostinil—Myalgia—Triamcinolone—psoriasis	0.000696	0.000799	CcSEcCtD
Treprostinil—Pneumonia—Methotrexate—psoriasis	0.000695	0.000797	CcSEcCtD
Treprostinil—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000694	0.000796	CcSEcCtD
Treprostinil—Decreased appetite—Cyclosporine—psoriasis	0.000693	0.000795	CcSEcCtD
Treprostinil—Tachycardia—Hydrocortisone—psoriasis	0.000692	0.000794	CcSEcCtD
Treprostinil—Depression—Methotrexate—psoriasis	0.000689	0.000791	CcSEcCtD
Treprostinil—Flushing—Prednisone—psoriasis	0.000689	0.00079	CcSEcCtD
Treprostinil—Ill-defined disorder—Betamethasone—psoriasis	0.000688	0.00079	CcSEcCtD
Treprostinil—Ill-defined disorder—Dexamethasone—psoriasis	0.000688	0.00079	CcSEcCtD
Treprostinil—Discomfort—Triamcinolone—psoriasis	0.000688	0.000789	CcSEcCtD
Treprostinil—Fatigue—Cyclosporine—psoriasis	0.000688	0.000789	CcSEcCtD
Treprostinil—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000685	0.000786	CcSEcCtD
Treprostinil—Pain—Cyclosporine—psoriasis	0.000682	0.000782	CcSEcCtD
Treprostinil—Angioedema—Dexamethasone—psoriasis	0.000678	0.000778	CcSEcCtD
Treprostinil—Angioedema—Betamethasone—psoriasis	0.000678	0.000778	CcSEcCtD
Treprostinil—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000676	0.000776	CcSEcCtD
Treprostinil—Anorexia—Hydrocortisone—psoriasis	0.000676	0.000775	CcSEcCtD
Treprostinil—Diarrhoea—Mycophenolic acid—psoriasis	0.000674	0.000774	CcSEcCtD
Treprostinil—Malaise—Dexamethasone—psoriasis	0.000669	0.000768	CcSEcCtD
Treprostinil—Malaise—Betamethasone—psoriasis	0.000669	0.000768	CcSEcCtD
Treprostinil—Oedema—Triamcinolone—psoriasis	0.000667	0.000766	CcSEcCtD
Treprostinil—Syncope—Dexamethasone—psoriasis	0.000665	0.000763	CcSEcCtD
Treprostinil—Syncope—Betamethasone—psoriasis	0.000665	0.000763	CcSEcCtD
Treprostinil—Pain—Mycophenolate mofetil—psoriasis	0.000665	0.000763	CcSEcCtD
Treprostinil—Infection—Triamcinolone—psoriasis	0.000663	0.000761	CcSEcCtD
Treprostinil—Hypotension—Hydrocortisone—psoriasis	0.000662	0.00076	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—psoriasis	0.000659	0.000756	CcSEcCtD
Treprostinil—Feeling abnormal—Cyclosporine—psoriasis	0.000657	0.000754	CcSEcCtD
Treprostinil—Shock—Triamcinolone—psoriasis	0.000657	0.000753	CcSEcCtD
Treprostinil—Insomnia—Prednisolone—psoriasis	0.000656	0.000753	CcSEcCtD
Treprostinil—Gastrointestinal pain—Cyclosporine—psoriasis	0.000652	0.000748	CcSEcCtD
Treprostinil—Loss of consciousness—Dexamethasone—psoriasis	0.000652	0.000748	CcSEcCtD
Treprostinil—Loss of consciousness—Betamethasone—psoriasis	0.000652	0.000748	CcSEcCtD
Treprostinil—Dizziness—Mycophenolic acid—psoriasis	0.000652	0.000748	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—psoriasis	0.000652	0.000748	CcSEcCtD
Treprostinil—Paraesthesia—Prednisolone—psoriasis	0.000652	0.000748	CcSEcCtD
Treprostinil—Tachycardia—Triamcinolone—psoriasis	0.000651	0.000747	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—HCAR2—psoriasis	0.00065	0.00506	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—STAT3—psoriasis	0.000648	0.00505	CbGpPWpGaD
Treprostinil—Erythema—Prednisone—psoriasis	0.000646	0.000741	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000646	0.000741	CcSEcCtD
Treprostinil—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000641	0.000736	CcSEcCtD
Treprostinil—Insomnia—Hydrocortisone—psoriasis	0.000641	0.000736	CcSEcCtD
Treprostinil—Paraesthesia—Hydrocortisone—psoriasis	0.000636	0.00073	CcSEcCtD
Treprostinil—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000636	0.00073	CcSEcCtD
Treprostinil—Myalgia—Betamethasone—psoriasis	0.000632	0.000725	CcSEcCtD
Treprostinil—Myalgia—Dexamethasone—psoriasis	0.000632	0.000725	CcSEcCtD
Treprostinil—Body temperature increased—Cyclosporine—psoriasis	0.00063	0.000723	CcSEcCtD
Treprostinil—Abdominal pain—Cyclosporine—psoriasis	0.00063	0.000723	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCL20—psoriasis	0.00063	0.0049	CbGpPWpGaD
Treprostinil—Anxiety—Dexamethasone—psoriasis	0.000629	0.000722	CcSEcCtD
Treprostinil—Anxiety—Betamethasone—psoriasis	0.000629	0.000722	CcSEcCtD
Treprostinil—Vomiting—Mycophenolic acid—psoriasis	0.000627	0.000719	CcSEcCtD
Treprostinil—Discomfort—Dexamethasone—psoriasis	0.000624	0.000716	CcSEcCtD
Treprostinil—Discomfort—Betamethasone—psoriasis	0.000624	0.000716	CcSEcCtD
Treprostinil—Dyspepsia—Hydrocortisone—psoriasis	0.000624	0.000716	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—psoriasis	0.000623	0.000715	CcSEcCtD
Treprostinil—Rash—Mycophenolic acid—psoriasis	0.000622	0.000713	CcSEcCtD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000621	0.00484	CbGpPWpGaD
Treprostinil—Dermatitis—Mycophenolic acid—psoriasis	0.000621	0.000712	CcSEcCtD
Treprostinil—Pain—Prednisolone—psoriasis	0.000621	0.000712	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—psoriasis	0.00062	0.000712	CcSEcCtD
Treprostinil—Headache—Mycophenolic acid—psoriasis	0.000618	0.000709	CcSEcCtD
Treprostinil—Decreased appetite—Hydrocortisone—psoriasis	0.000616	0.000707	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—psoriasis	0.000616	0.000706	CcSEcCtD
Treprostinil—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000615	0.000706	CcSEcCtD
Treprostinil—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000615	0.000706	CcSEcCtD
Treprostinil—Fatigue—Hydrocortisone—psoriasis	0.000611	0.000701	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000608	0.000698	CcSEcCtD
Treprostinil—Pain—Hydrocortisone—psoriasis	0.000606	0.000695	CcSEcCtD
Treprostinil—Oedema—Betamethasone—psoriasis	0.000605	0.000695	CcSEcCtD
Treprostinil—Oedema—Dexamethasone—psoriasis	0.000605	0.000695	CcSEcCtD
Treprostinil—Insomnia—Triamcinolone—psoriasis	0.000604	0.000693	CcSEcCtD
Treprostinil—Infection—Betamethasone—psoriasis	0.000602	0.00069	CcSEcCtD
Treprostinil—Infection—Dexamethasone—psoriasis	0.000602	0.00069	CcSEcCtD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—psoriasis	0.000601	0.00468	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Prednisone—psoriasis	0.000599	0.000688	CcSEcCtD
Treprostinil—Paraesthesia—Triamcinolone—psoriasis	0.000599	0.000688	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—HCAR2—psoriasis	0.000598	0.00466	CbGpPWpGaD
Treprostinil—Feeling abnormal—Prednisolone—psoriasis	0.000598	0.000686	CcSEcCtD
Treprostinil—Anaemia—Prednisone—psoriasis	0.000597	0.000685	CcSEcCtD
Treprostinil—Shock—Dexamethasone—psoriasis	0.000596	0.000684	CcSEcCtD
Treprostinil—Shock—Betamethasone—psoriasis	0.000596	0.000684	CcSEcCtD
Treprostinil—Dyspnoea—Triamcinolone—psoriasis	0.000595	0.000683	CcSEcCtD
Treprostinil—Thrombocytopenia—Dexamethasone—psoriasis	0.000593	0.00068	CcSEcCtD
Treprostinil—Thrombocytopenia—Betamethasone—psoriasis	0.000593	0.00068	CcSEcCtD
Treprostinil—Tachycardia—Dexamethasone—psoriasis	0.000591	0.000678	CcSEcCtD
Treprostinil—Tachycardia—Betamethasone—psoriasis	0.000591	0.000678	CcSEcCtD
Treprostinil—Angioedema—Prednisone—psoriasis	0.00059	0.000677	CcSEcCtD
Treprostinil—Dyspepsia—Triamcinolone—psoriasis	0.000587	0.000674	CcSEcCtD
Treprostinil—Nausea—Mycophenolic acid—psoriasis	0.000586	0.000672	CcSEcCtD
Treprostinil—Feeling abnormal—Hydrocortisone—psoriasis	0.000584	0.00067	CcSEcCtD
Treprostinil—Malaise—Prednisone—psoriasis	0.000583	0.000669	CcSEcCtD
Treprostinil—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00058	0.000665	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CCL20—psoriasis	0.000579	0.00451	CbGpPWpGaD
Treprostinil—Syncope—Prednisone—psoriasis	0.000579	0.000665	CcSEcCtD
Treprostinil—Anorexia—Dexamethasone—psoriasis	0.000577	0.000662	CcSEcCtD
Treprostinil—Anorexia—Betamethasone—psoriasis	0.000577	0.000662	CcSEcCtD
Treprostinil—Fatigue—Triamcinolone—psoriasis	0.000575	0.00066	CcSEcCtD
Treprostinil—Asthenia—Cyclosporine—psoriasis	0.000572	0.000657	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCL20—psoriasis	0.000572	0.00445	CbGpPWpGaD
Treprostinil—Pain—Triamcinolone—psoriasis	0.000571	0.000655	CcSEcCtD
Treprostinil—Loss of consciousness—Prednisone—psoriasis	0.000568	0.000652	CcSEcCtD
Treprostinil—Hypotension—Betamethasone—psoriasis	0.000566	0.000649	CcSEcCtD
Treprostinil—Hypotension—Dexamethasone—psoriasis	0.000566	0.000649	CcSEcCtD
Treprostinil—Pruritus—Cyclosporine—psoriasis	0.000564	0.000647	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—TAGAP—psoriasis	0.000564	0.00439	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TNF—psoriasis	0.000561	0.00437	CbGpPWpGaD
Treprostinil—Abdominal pain—Hydrocortisone—psoriasis	0.00056	0.000643	CcSEcCtD
Treprostinil—Body temperature increased—Hydrocortisone—psoriasis	0.00056	0.000643	CcSEcCtD
Treprostinil—Asthenia—Mycophenolate mofetil—psoriasis	0.000558	0.00064	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—VDR—psoriasis	0.000554	0.00431	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000552	0.000633	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000552	0.000633	CcSEcCtD
Treprostinil—Pruritus—Mycophenolate mofetil—psoriasis	0.00055	0.000632	CcSEcCtD
Treprostinil—Myalgia—Prednisone—psoriasis	0.00055	0.000631	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—psoriasis	0.00055	0.000631	CcSEcCtD
Treprostinil—Feeling abnormal—Triamcinolone—psoriasis	0.00055	0.000631	CcSEcCtD
Treprostinil—Anxiety—Prednisone—psoriasis	0.000548	0.000629	CcSEcCtD
Treprostinil—Insomnia—Dexamethasone—psoriasis	0.000548	0.000628	CcSEcCtD
Treprostinil—Insomnia—Betamethasone—psoriasis	0.000548	0.000628	CcSEcCtD
Treprostinil—Diarrhoea—Cyclosporine—psoriasis	0.000546	0.000626	CcSEcCtD
Treprostinil—Paraesthesia—Dexamethasone—psoriasis	0.000544	0.000624	CcSEcCtD
Treprostinil—Paraesthesia—Betamethasone—psoriasis	0.000544	0.000624	CcSEcCtD
Treprostinil—Discomfort—Prednisone—psoriasis	0.000543	0.000624	CcSEcCtD
Treprostinil—Erythema—Methotrexate—psoriasis	0.00054	0.00062	CcSEcCtD
Treprostinil—Dyspepsia—Dexamethasone—psoriasis	0.000533	0.000612	CcSEcCtD
Treprostinil—Dyspepsia—Betamethasone—psoriasis	0.000533	0.000612	CcSEcCtD
Treprostinil—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000532	0.000611	CcSEcCtD
Treprostinil—Body temperature increased—Triamcinolone—psoriasis	0.000528	0.000605	CcSEcCtD
Treprostinil—Dizziness—Cyclosporine—psoriasis	0.000527	0.000605	CcSEcCtD
Treprostinil—Oedema—Prednisone—psoriasis	0.000527	0.000605	CcSEcCtD
Treprostinil—Decreased appetite—Dexamethasone—psoriasis	0.000526	0.000604	CcSEcCtD
Treprostinil—Decreased appetite—Betamethasone—psoriasis	0.000526	0.000604	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CCL20—psoriasis	0.000526	0.0041	CbGpPWpGaD
Treprostinil—Infection—Prednisone—psoriasis	0.000524	0.000601	CcSEcCtD
Treprostinil—Back pain—Methotrexate—psoriasis	0.000522	0.000599	CcSEcCtD
Treprostinil—Fatigue—Dexamethasone—psoriasis	0.000522	0.000599	CcSEcCtD
Treprostinil—Fatigue—Betamethasone—psoriasis	0.000522	0.000599	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—TAGAP—psoriasis	0.000519	0.00404	CbGpPWpGaD
Treprostinil—Shock—Prednisone—psoriasis	0.000519	0.000595	CcSEcCtD
Treprostinil—Pain—Betamethasone—psoriasis	0.000518	0.000594	CcSEcCtD
Treprostinil—Pain—Dexamethasone—psoriasis	0.000518	0.000594	CcSEcCtD
Treprostinil—Tachycardia—Prednisone—psoriasis	0.000515	0.000591	CcSEcCtD
Treprostinil—Dizziness—Mycophenolate mofetil—psoriasis	0.000514	0.00059	CcSEcCtD
Treprostinil—Asthenia—Hydrocortisone—psoriasis	0.000508	0.000583	CcSEcCtD
Treprostinil—Vomiting—Cyclosporine—psoriasis	0.000507	0.000582	CcSEcCtD
Treprostinil—Rash—Cyclosporine—psoriasis	0.000503	0.000577	CcSEcCtD
Treprostinil—Anorexia—Prednisone—psoriasis	0.000503	0.000577	CcSEcCtD
Treprostinil—Dermatitis—Cyclosporine—psoriasis	0.000502	0.000576	CcSEcCtD
Treprostinil—Pruritus—Hydrocortisone—psoriasis	0.000501	0.000575	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—psoriasis	0.000501	0.000575	CcSEcCtD
Treprostinil—Headache—Cyclosporine—psoriasis	0.0005	0.000573	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—psoriasis	0.000499	0.000573	CcSEcCtD
Treprostinil—Feeling abnormal—Betamethasone—psoriasis	0.000499	0.000573	CcSEcCtD
Treprostinil—Feeling abnormal—Dexamethasone—psoriasis	0.000499	0.000573	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL8—psoriasis	0.000497	0.00387	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Betamethasone—psoriasis	0.000495	0.000568	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dexamethasone—psoriasis	0.000495	0.000568	CcSEcCtD
Treprostinil—Vomiting—Mycophenolate mofetil—psoriasis	0.000495	0.000568	CcSEcCtD
Treprostinil—Rash—Mycophenolate mofetil—psoriasis	0.00049	0.000563	CcSEcCtD
Treprostinil—Dermatitis—Mycophenolate mofetil—psoriasis	0.00049	0.000562	CcSEcCtD
Treprostinil—Headache—Mycophenolate mofetil—psoriasis	0.000487	0.000559	CcSEcCtD
Treprostinil—Malaise—Methotrexate—psoriasis	0.000487	0.000559	CcSEcCtD
Treprostinil—Diarrhoea—Hydrocortisone—psoriasis	0.000485	0.000556	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Prednisone—psoriasis	0.00048	0.000551	CcSEcCtD
Treprostinil—Dizziness—Prednisolone—psoriasis	0.00048	0.000551	CcSEcCtD
Treprostinil—Asthenia—Triamcinolone—psoriasis	0.000479	0.000549	CcSEcCtD
Treprostinil—Abdominal pain—Betamethasone—psoriasis	0.000479	0.000549	CcSEcCtD
Treprostinil—Body temperature increased—Dexamethasone—psoriasis	0.000479	0.000549	CcSEcCtD
Treprostinil—Abdominal pain—Dexamethasone—psoriasis	0.000479	0.000549	CcSEcCtD
Treprostinil—Body temperature increased—Betamethasone—psoriasis	0.000479	0.000549	CcSEcCtD
Treprostinil—Insomnia—Prednisone—psoriasis	0.000477	0.000547	CcSEcCtD
Treprostinil—Nausea—Cyclosporine—psoriasis	0.000474	0.000544	CcSEcCtD
Treprostinil—Paraesthesia—Prednisone—psoriasis	0.000473	0.000543	CcSEcCtD
Treprostinil—Pruritus—Triamcinolone—psoriasis	0.000472	0.000542	CcSEcCtD
Treprostinil—Cough—Methotrexate—psoriasis	0.000471	0.000541	CcSEcCtD
Treprostinil—Dizziness—Hydrocortisone—psoriasis	0.000469	0.000538	CcSEcCtD
Treprostinil—Dyspepsia—Prednisone—psoriasis	0.000464	0.000533	CcSEcCtD
Treprostinil—Nausea—Mycophenolate mofetil—psoriasis	0.000462	0.00053	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—psoriasis	0.00046	0.000527	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—psoriasis	0.00046	0.000527	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—psoriasis	0.00046	0.000527	CcSEcCtD
Treprostinil—Decreased appetite—Prednisone—psoriasis	0.000458	0.000526	CcSEcCtD
Treprostinil—Rash—Prednisolone—psoriasis	0.000458	0.000525	CcSEcCtD
Treprostinil—Dermatitis—Prednisolone—psoriasis	0.000457	0.000525	CcSEcCtD
Treprostinil—Fatigue—Prednisone—psoriasis	0.000455	0.000522	CcSEcCtD
Treprostinil—Headache—Prednisolone—psoriasis	0.000455	0.000522	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—psoriasis	0.000454	0.000521	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—IL6—psoriasis	0.000453	0.00353	CbGpPWpGaD
Treprostinil—Vomiting—Hydrocortisone—psoriasis	0.000451	0.000517	CcSEcCtD
Treprostinil—Rash—Hydrocortisone—psoriasis	0.000447	0.000513	CcSEcCtD
Treprostinil—Dermatitis—Hydrocortisone—psoriasis	0.000446	0.000512	CcSEcCtD
Treprostinil—PPARD—Gene Expression—CARM1—psoriasis	0.000446	0.00347	CbGpPWpGaD
Treprostinil—Headache—Hydrocortisone—psoriasis	0.000444	0.000509	CcSEcCtD
Treprostinil—Dizziness—Triamcinolone—psoriasis	0.000441	0.000506	CcSEcCtD
Treprostinil—Infection—Methotrexate—psoriasis	0.000438	0.000502	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisone—psoriasis	0.000435	0.000499	CcSEcCtD
Treprostinil—Asthenia—Dexamethasone—psoriasis	0.000434	0.000498	CcSEcCtD
Treprostinil—Asthenia—Betamethasone—psoriasis	0.000434	0.000498	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—psoriasis	0.000431	0.000495	CcSEcCtD
Treprostinil—Gastrointestinal pain—Prednisone—psoriasis	0.000431	0.000495	CcSEcCtD
Treprostinil—Nausea—Prednisolone—psoriasis	0.000431	0.000495	CcSEcCtD
Treprostinil—Pruritus—Dexamethasone—psoriasis	0.000428	0.000492	CcSEcCtD
Treprostinil—Pruritus—Betamethasone—psoriasis	0.000428	0.000492	CcSEcCtD
Treprostinil—Vomiting—Triamcinolone—psoriasis	0.000424	0.000487	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000424	0.0033	CbGpPWpGaD
Treprostinil—Nausea—Hydrocortisone—psoriasis	0.000421	0.000483	CcSEcCtD
Treprostinil—Rash—Triamcinolone—psoriasis	0.000421	0.000483	CcSEcCtD
Treprostinil—Dermatitis—Triamcinolone—psoriasis	0.00042	0.000482	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—psoriasis	0.00042	0.000482	CcSEcCtD
Treprostinil—Headache—Triamcinolone—psoriasis	0.000418	0.00048	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—psoriasis	0.000417	0.000478	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—psoriasis	0.000417	0.000478	CcSEcCtD
Treprostinil—Diarrhoea—Betamethasone—psoriasis	0.000414	0.000475	CcSEcCtD
Treprostinil—Diarrhoea—Dexamethasone—psoriasis	0.000414	0.000475	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—psoriasis	0.000412	0.000473	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000402	0.000461	CcSEcCtD
Treprostinil—Dizziness—Betamethasone—psoriasis	0.0004	0.000459	CcSEcCtD
Treprostinil—Dizziness—Dexamethasone—psoriasis	0.0004	0.000459	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—psoriasis	0.000399	0.000457	CcSEcCtD
Treprostinil—Nausea—Triamcinolone—psoriasis	0.000396	0.000455	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—psoriasis	0.000396	0.000454	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000395	0.00307	CbGpPWpGaD
Treprostinil—Dyspnoea—Methotrexate—psoriasis	0.000393	0.000451	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—psoriasis	0.000388	0.000445	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—PPARG—psoriasis	0.000386	0.003	CbGpPWpGaD
Treprostinil—Vomiting—Betamethasone—psoriasis	0.000385	0.000442	CcSEcCtD
Treprostinil—Vomiting—Dexamethasone—psoriasis	0.000385	0.000442	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—psoriasis	0.000383	0.00044	CcSEcCtD
Treprostinil—Rash—Betamethasone—psoriasis	0.000382	0.000438	CcSEcCtD
Treprostinil—Rash—Dexamethasone—psoriasis	0.000382	0.000438	CcSEcCtD
Treprostinil—Dermatitis—Dexamethasone—psoriasis	0.000381	0.000438	CcSEcCtD
Treprostinil—Dermatitis—Betamethasone—psoriasis	0.000381	0.000438	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—psoriasis	0.00038	0.000436	CcSEcCtD
Treprostinil—Headache—Betamethasone—psoriasis	0.000379	0.000435	CcSEcCtD
Treprostinil—Headache—Dexamethasone—psoriasis	0.000379	0.000435	CcSEcCtD
Treprostinil—Asthenia—Prednisone—psoriasis	0.000378	0.000434	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—NOS2—psoriasis	0.000377	0.00294	CbGpPWpGaD
Treprostinil—Pain—Methotrexate—psoriasis	0.000377	0.000432	CcSEcCtD
Treprostinil—Pruritus—Prednisone—psoriasis	0.000373	0.000428	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000372	0.0029	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000364	0.00283	CbGpPWpGaD
Treprostinil—Feeling abnormal—Methotrexate—psoriasis	0.000363	0.000417	CcSEcCtD
Treprostinil—Diarrhoea—Prednisone—psoriasis	0.000361	0.000414	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—psoriasis	0.00036	0.000413	CcSEcCtD
Treprostinil—Nausea—Betamethasone—psoriasis	0.00036	0.000413	CcSEcCtD
Treprostinil—Nausea—Dexamethasone—psoriasis	0.00036	0.000413	CcSEcCtD
Treprostinil—Dizziness—Prednisone—psoriasis	0.000349	0.0004	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—psoriasis	0.000348	0.0004	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—psoriasis	0.000348	0.0004	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—NOS2—psoriasis	0.000347	0.0027	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CARM1—psoriasis	0.000347	0.0027	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL20—psoriasis	0.000338	0.00263	CbGpPWpGaD
Treprostinil—Vomiting—Prednisone—psoriasis	0.000335	0.000385	CcSEcCtD
Treprostinil—Rash—Prednisone—psoriasis	0.000332	0.000381	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—psoriasis	0.000332	0.000381	CcSEcCtD
Treprostinil—Headache—Prednisone—psoriasis	0.00033	0.000379	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000324	0.00252	CbGpPWpGaD
Treprostinil—Asthenia—Methotrexate—psoriasis	0.000316	0.000363	CcSEcCtD
Treprostinil—Nausea—Prednisone—psoriasis	0.000313	0.000359	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—psoriasis	0.000312	0.000358	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CCL20—psoriasis	0.000311	0.00242	CbGpPWpGaD
Treprostinil—Diarrhoea—Methotrexate—psoriasis	0.000302	0.000346	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CXCL8—psoriasis	0.000301	0.00234	CbGpPWpGaD
Treprostinil—Dizziness—Methotrexate—psoriasis	0.000291	0.000334	CcSEcCtD
Treprostinil—Vomiting—Methotrexate—psoriasis	0.00028	0.000322	CcSEcCtD
Treprostinil—Rash—Methotrexate—psoriasis	0.000278	0.000319	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—psoriasis	0.000278	0.000319	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—psoriasis	0.000277	0.00215	CbGpPWpGaD
Treprostinil—Headache—Methotrexate—psoriasis	0.000276	0.000317	CcSEcCtD
Treprostinil—PPARD—Gene Expression—VDR—psoriasis	0.000267	0.00207	CbGpPWpGaD
Treprostinil—Nausea—Methotrexate—psoriasis	0.000262	0.0003	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—VEGFA—psoriasis	0.000219	0.0017	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAT—psoriasis	0.000213	0.00166	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—psoriasis	0.000201	0.00157	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SOCS1—psoriasis	0.000186	0.00145	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—psoriasis	0.000186	0.00145	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—TYK2—psoriasis	0.000177	0.00138	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SOCS1—psoriasis	0.000171	0.00133	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—psoriasis	0.00017	0.00132	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NDUFA5—psoriasis	0.000168	0.00131	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—psoriasis	0.000166	0.00129	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—psoriasis	0.000165	0.00129	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TYK2—psoriasis	0.000163	0.00127	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000157	0.00122	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—psoriasis	0.000156	0.00122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—psoriasis	0.000154	0.0012	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—psoriasis	0.000152	0.00118	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—psoriasis	0.000144	0.00112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2S1—psoriasis	0.000143	0.00111	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—psoriasis	0.000142	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—psoriasis	0.000137	0.00107	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—psoriasis	0.000137	0.00107	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKBIA—psoriasis	0.000128	0.000995	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—psoriasis	0.000126	0.000983	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—psoriasis	0.000126	0.000983	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKBIA—psoriasis	0.000118	0.000916	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TYK2—psoriasis	0.000105	0.000815	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TYK2—psoriasis	9.64e-05	0.00075	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—psoriasis	9.12e-05	0.00071	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—psoriasis	8.67e-05	0.000675	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—psoriasis	8.48e-05	0.00066	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—psoriasis	8.39e-05	0.000653	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKB1—psoriasis	8.16e-05	0.000635	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—psoriasis	7.98e-05	0.000621	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—psoriasis	7.8e-05	0.000607	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKB1—psoriasis	7.51e-05	0.000585	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.49e-05	0.000583	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—psoriasis	7.41e-05	0.000577	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—psoriasis	7.34e-05	0.000571	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CARM1—psoriasis	6.98e-05	0.000543	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—psoriasis	6.82e-05	0.000531	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—psoriasis	6.75e-05	0.000525	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.52e-05	0.000508	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—psoriasis	5.6e-05	0.000436	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—psoriasis	5.15e-05	0.000401	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—psoriasis	5.12e-05	0.000399	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—psoriasis	4.72e-05	0.000367	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAT—psoriasis	4.29e-05	0.000334	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—psoriasis	3.34e-05	0.00026	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—psoriasis	2.9e-05	0.000226	CbGpPWpGaD
